RYCMX
Price
$45.13
Change
-$0.78 (-1.70%)
Updated
Oct 7 closing price
Net Assets
7.98M
RYVLX
Price
$704.98
Change
-$7.98 (-1.12%)
Updated
Oct 7 closing price
Net Assets
1.37B
Interact to see
Advertisement

RYCMX vs RYVLX

Header iconRYCMX vs RYVLX Comparison
Open Charts RYCMX vs RYVLXBanner chart's image
Rydex Russell 2000 1.5x Strategy C
Price$45.13
Change-$0.78 (-1.70%)
VolumeN/A
Net Assets7.98M
Rydex NASDAQ-100® 2x Strategy A
Price$704.98
Change-$7.98 (-1.12%)
VolumeN/A
Net Assets1.37B
RYCMX vs RYVLX Comparison Chart in %
View a ticker or compare two or three
VS
RYCMX vs. RYVLX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCMX is a Buy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.37B vs. RYCMX (7.98M). RYCMX pays higher dividends than RYVLX: RYCMX (1.64) vs RYVLX (0.00). RYCMX was incepted earlier than RYVLX: RYCMX (25 years) vs RYVLX (21 years). RYCMX (2.52) is less costly to investors than RYVLX (1.87). RYVLX is a more actively managed with annual turnover of: 383.00 vs. RYCMX (10.00). RYCMX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 35.48 vs. RYCMX (15.25). RYVLX return over 5 years is better than : 141.93 vs. RYCMX (-13.22).
RYCMXRYVLXRYCMX / RYVLX
Total Expense Ratio2.391.74137%
Annual Report Gross Expense Ratio2.521.87135%
Fund Existence25 years21 years-
Gain YTD13.66729.49546%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets7.98M1.37B1%
Annual Yield % from dividends1.640.00-
Returns for 1 year15.2535.4843%
Returns for 3 years55.59258.1122%
Returns for 5 years-13.22141.93-9%
Returns for 10 years1.43868.960%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AROC24.340.29
+1.21%
Archrock
TAK14.46-0.09
-0.62%
Takeda Pharmaceutical Company Limited
LCNB14.52-0.21
-1.43%
LCNB Corp
SG7.76-0.17
-2.14%
Sweetgreen
FBLG0.49-0.06
-10.82%
FibroBiologics